Kyounggi-do, South Korea

Jae-Weung Lee


Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Jae-Weung Lee

Introduction: Jae-Weung Lee, an inventive mind hailing from Kyounggi-do, South Korea, has made significant strides in the field of antiviral research. With a focus on developing new therapeutic agents, he holds a notable patent that showcases his contribution to innovative solutions in healthcare.

Latest Patents: Jae-Weung Lee is recognized for his patent, titled "Antiviral 2,4-pyrimidinedione derivatives and process for the." This invention represents his commitment to advancing antiviral agents, providing a basis for future research and development in treating viral infections.

Career Highlights: Throughout his career, Jae-Weung Lee has been associated with prominent institutions that have played a critical role in his professional growth. He has worked at the Korea Research Institute of Chemical Technology, where he contributed to groundbreaking research initiatives. Additionally, his tenure at Samjin Pharmaceutical Co., Ltd. allowed him to further develop his expertise in pharmaceutical innovations.

Collaborations: Jae-Weung Lee's work has not gone unnoticed, as he has collaborated with esteemed colleagues in the field, notably Jong-Chan Son and Iii Young Lee. These partnerships have fostered a collaborative environment that encourages shared learning and innovation.

Conclusion: Jae-Weung Lee's journey as an inventor is marked by his dedication to developing antiviral solutions and his integral role within renowned organizations. His patent underscores the impact of his research on public health, and his collaborations signify the importance of working together to drive innovation forward.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…